Literature DB >> 16477437

WNT10B mutations in human obesity.

C Christodoulides1, A Scarda, M Granzotto, G Milan, E Dalla Nora, J Keogh, G De Pergola, H Stirling, N Pannacciulli, J K Sethi, G Federspil, A Vidal-Puig, I S Farooqi, S O'Rahilly, R Vettor.   

Abstract

AIMS/HYPOTHESIS: Recent studies suggest that wingless-type MMTV integration site family, member 10B (WNT10B) may play a role in the negative regulation of adipocyte differentiation in vitro and in vivo. In order to determine whether mutations in WNT10B contribute to human obesity, we screened two independent populations of obese subjects for mutations in this gene. SUBJECTS AND METHODS: We studied 96 subjects with severe obesity of early onset (less than 10 years of age) from the UK Genetics of Obesity Study and 115 obese Italian subjects of European origin.
RESULTS: One proband with early-onset obesity was found to be heterozygous for a C256Y mutation, which abrogated the ability of WNT10B to activate canonical WNT signalling and block adipogenesis and was not found in 600 control alleles. All relatives of the proband who carried this allele were either overweight or obese. Three other rare missense variants were found in obese probands, but these did not clearly cosegregate with obesity in family studies and one (P301S), which was found in three unrelated subjects with early-onset obesity, had normal functional properties. CONCLUSIONS/
INTERPRETATION: These mutations represent the first naturally occurring missense variants of WNT10B. While the pedigree analysis in the case of C256Y WNT10B does not provide definitive proof of a causal link of this variant with obesity, the finding of a non-functioning WNT10B allele in a human family affected by obesity should encourage further study of this gene in other obese populations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16477437      PMCID: PMC4304000          DOI: 10.1007/s00125-006-0144-4

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  18 in total

Review 1.  Adipogenesis: forces that tip the scales.

Authors:  Ormond A MacDougald; Susanne Mandrup
Journal:  Trends Endocrinol Metab       Date:  2002 Jan-Feb       Impact factor: 12.015

Review 2.  The Wnt signaling pathway in development and disease.

Authors:  Catriona Y Logan; Roel Nusse
Journal:  Annu Rev Cell Dev Biol       Date:  2004       Impact factor: 13.827

3.  British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood.

Authors:  T J Cole; J V Freeman; M A Preece
Journal:  Stat Med       Date:  1998-02-28       Impact factor: 2.373

4.  Regulation of osteoblastogenesis and bone mass by Wnt10b.

Authors:  Christina N Bennett; Kenneth A Longo; Wendy S Wright; Larry J Suva; Timothy F Lane; Kurt D Hankenson; Ormond A MacDougald
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

5.  Potentiation of glucose uptake in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: evidence for selectivity in the downstream responses to PPAR gamma activation.

Authors:  C Nugent; J B Prins; J P Whitehead; D Savage; J M Wentworth; V K Chatterjee; S O'Rahilly
Journal:  Mol Endocrinol       Date:  2001-10

6.  Wnt proteins are lipid-modified and can act as stem cell growth factors.

Authors:  Karl Willert; Jeffrey D Brown; Esther Danenberg; Andrew W Duncan; Irving L Weissman; Tannishtha Reya; John R Yates; Roel Nusse
Journal:  Nature       Date:  2003-04-27       Impact factor: 49.962

7.  Studies of the peptide YY and neuropeptide Y2 receptor genes in relation to human obesity and obesity-related traits.

Authors:  Chiao-Chien Connie Hung; Fraser Pirie; Jian'an Luan; Emma Lank; Ayesha Motala; Giles S H Yeo; Julia M Keogh; Nicholas J Wareham; Stephen O'Rahilly; I Sadaf Farooqi
Journal:  Diabetes       Date:  2004-09       Impact factor: 9.461

8.  Wnt10b inhibits development of white and brown adipose tissues.

Authors:  Kenneth A Longo; Wendy S Wright; Sona Kang; Isabelle Gerin; Shian-Huey Chiang; Peter C Lucas; Mark R Opp; Ormond A MacDougald
Journal:  J Biol Chem       Date:  2004-06-09       Impact factor: 5.157

9.  Functional analysis of Wingless reveals a link between intercellular ligand transport and dorsal-cell-specific signaling.

Authors:  H A Dierick; A Bejsovec
Journal:  Development       Date:  1998-12       Impact factor: 6.868

Review 10.  The Wnts.

Authors:  Jeffrey R Miller
Journal:  Genome Biol       Date:  2001-12-28       Impact factor: 13.583

View more
  53 in total

1.  TCF7L2 and type 2 diabetes--we WNT to know.

Authors:  U Smith
Journal:  Diabetologia       Date:  2006-11-11       Impact factor: 10.122

2.  Rosiglitazone modifies the adipogenic potential of human muscle satellite cells.

Authors:  P De Coppi; G Milan; A Scarda; L Boldrin; C Centobene; M Piccoli; M Pozzobon; C Pilon; C Pagano; P Gamba; R Vettor
Journal:  Diabetologia       Date:  2006-06-24       Impact factor: 10.122

Review 3.  Wnt/beta-catenin signaling in adipogenesis and metabolism.

Authors:  Tyler C Prestwich; Ormond A Macdougald
Journal:  Curr Opin Cell Biol       Date:  2007-11-09       Impact factor: 8.382

Review 4.  Wnt/beta-catenin signaling: components, mechanisms, and diseases.

Authors:  Bryan T MacDonald; Keiko Tamai; Xi He
Journal:  Dev Cell       Date:  2009-07       Impact factor: 12.270

5.  The influence of Leucine-rich amelogenin peptide on MSC fate by inducing Wnt10b expression.

Authors:  Xin Wen; William P Cawthorn; Ormond A MacDougald; Samuel I Stupp; Malcolm L Snead; Yan Zhou
Journal:  Biomaterials       Date:  2011-06-12       Impact factor: 12.479

Review 6.  Wnt signaling and the control of human stem cell fate.

Authors:  J K Van Camp; S Beckers; D Zegers; W Van Hul
Journal:  Stem Cell Rev Rep       Date:  2014-04       Impact factor: 5.739

Review 7.  Wnt modulators in the biotech pipeline.

Authors:  Jean-Philippe Rey; Debra L Ellies
Journal:  Dev Dyn       Date:  2010-01       Impact factor: 3.780

8.  Bidirectional modulation of adipogenesis by the secreted protein Ccdc80/DRO1/URB.

Authors:  Frédéric Tremblay; Tracy Revett; Christine Huard; Ying Zhang; James F Tobin; Robert V Martinez; Ruth E Gimeno
Journal:  J Biol Chem       Date:  2009-01-13       Impact factor: 5.157

9.  A deep investigation into the adipogenesis mechanism: profile of microRNAs regulating adipogenesis by modulating the canonical Wnt/beta-catenin signaling pathway.

Authors:  Limei Qin; Yaosheng Chen; Yuna Niu; Weiquan Chen; Qiwei Wang; Shuqi Xiao; Anning Li; Ying Xie; Jing Li; Xiao Zhao; Zuyong He; Delin Mo
Journal:  BMC Genomics       Date:  2010-05-23       Impact factor: 3.969

10.  Dact1, a nutritionally regulated preadipocyte gene, controls adipogenesis by coordinating the Wnt/beta-catenin signaling network.

Authors:  Claire Lagathu; Constantinos Christodoulides; Sam Virtue; William P Cawthorn; Chiara Franzin; Wendy A Kimber; Edoardo Dalla Nora; Mark Campbell; Gema Medina-Gomez; Benjamin N R Cheyette; Antonio J Vidal-Puig; Jaswinder K Sethi
Journal:  Diabetes       Date:  2008-12-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.